MedPath

The PRICE Trial: Pain Reduction for Intrauterine Contraception Experiment

Phase 2
Recruiting
Conditions
Contraception
Registration Number
NCT06532162
Lead Sponsor
Mount Sinai Hospital, Canada
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
246
Inclusion Criteria

Inclusion Criteria:<br><br> - Any participant presenting for an IUD placement, either for contraception or<br> treatment of abnormal uterine bleeding or to regulate menstrual periods<br><br> - All IUDs (copper, hormonal) eligible<br><br> - All parities of patients are eligible<br><br>Exclusion Criteria:<br><br> - Use of pain medication that is not an NSAID or acetaminophen (e.g. opioids,<br> benzodiazepines) within past 24 hours<br><br> - Confirmed pregnancy<br><br> - Any diagnosed chronic pain conditions (fibromyalgia, vaginismus, interstitial<br> cystitis)<br><br> - Misoprostol administration within 24 hours of enrollment<br><br> - Known contraindications to IUD placement<br><br> - Contraindication to lidocaine<br><br> - IUD exchange<br><br> - Previous unsuccessful attempt for IUD by the same practitioner

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Global Pain Score
Secondary Outcome Measures
NameTimeMethod
Pain at specific pain points;Immediate complications following the procedure (i.e. vasovagal response, dizziness, local anesthetic toxicity syndrome);Length of time for analgesia;Length of time for IUD placement;Patient satisfaction;Difficulty of IUD placement
© Copyright 2025. All Rights Reserved by MedPath